Total Payments
$13,154
2024 Payments
$5,491
Companies
24
Transactions
665
Medicare Patients
809
Medicare Billing
$117,780
Payment Breakdown by Category
Food & Beverage$10,832 (82.3%)
Travel$2,203 (16.7%)
Education$119.64 (0.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,832 | 654 | 82.3% |
| Travel and Lodging | $2,203 | 7 | 16.7% |
| Education | $119.64 | 4 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $3,547 | 67 | $0 (2024) |
| Alkermes, Inc. | $1,339 | 60 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $1,227 | 93 | $0 (2024) |
| Lundbeck LLC | $1,098 | 62 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $893.82 | 60 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $785.34 | 53 | $0 (2024) |
| ABBVIE INC. | $766.53 | 56 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $661.60 | 43 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $584.34 | 33 | $0 (2024) |
| Axsome Therapeutics, Inc. | $360.48 | 22 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,491 | 207 | Janssen Pharmaceuticals, Inc ($2,769) |
| 2023 | $3,805 | 228 | Supernus Pharmaceuticals, Inc. ($413.06) |
| 2022 | $2,621 | 150 | Alkermes, Inc. ($518.46) |
| 2021 | $1,236 | 80 | Otsuka America Pharmaceutical, Inc. ($274.76) |
All Payment Transactions
665 individual payment records from CMS Open Payments — Page 1 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $33.12 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/19/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $9.44 | General |
| Category: Neurology | ||||||
| 12/19/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $5.60 | General |
| Category: Neuropsychiatry | ||||||
| 12/18/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: PSYCHIATRY | ||||||
| 12/12/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $18.94 | General |
| Category: PSYCHIATRY | ||||||
| 12/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.48 | General |
| Category: NEUROSCIENCE | ||||||
| 12/10/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $27.92 | General |
| Category: Neuropsychiatry | ||||||
| 12/09/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $4.50 | General |
| Category: Neuroscience | ||||||
| 12/08/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $23.27 | General |
| Category: CNS | ||||||
| 12/05/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: PSYCHIATRY | ||||||
| 12/04/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: PSYCHIATRY | ||||||
| 12/04/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $8.95 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 12/03/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $25.52 | General |
| Category: Neuroscience | ||||||
| 11/26/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $28.99 | General |
| Category: CNS | ||||||
| 11/26/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: Neuropsychiatry | ||||||
| 11/25/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $6.61 | General |
| Category: Neurology | ||||||
| 11/21/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $19.34 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 11/21/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $19.11 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/21/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: PSYCHIATRY | ||||||
| 11/21/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $6.30 | General |
| Category: Neuropsychiatry | ||||||
| 11/21/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $2.33 | General |
| Category: PSYCHIATRY | ||||||
| 11/20/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $22.98 | General |
| Category: PSYCHIATRY | ||||||
| 11/18/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | Cash or cash equivalent | $22.22 | General |
| Category: SCHIZOPHRENIA | ||||||
| 11/14/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $12.77 | General |
| Category: PSYCHIATRY | ||||||
| 11/14/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $7.68 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 73 | 215 | $33,790 | $13,619 |
| 2022 | 4 | 116 | 289 | $45,490 | $19,179 |
| 2021 | 7 | 196 | 354 | $47,605 | $22,031 |
| 2020 | 4 | 424 | 1,255 | $140,734 | $62,952 |
Total Patients
809
Total Services
2,113
Medicare Billing
$117,780
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 34 | 129 | $21,930 | $9,561 | 43.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 28 | 73 | $10,950 | $3,640 | 33.2% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 11 | 13 | $910.00 | $417.39 | 45.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 50 | 163 | $27,710 | $11,772 | 42.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 31 | 76 | $11,400 | $3,852 | 33.8% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 16 | 16 | $4,000 | $2,040 | 51.0% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 19 | 34 | $2,380 | $1,515 | 63.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 33 | 116 | $19,720 | $9,349 | 47.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 70 | 140 | $14,140 | $6,545 | 46.3% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 24 | 24 | $6,000 | $2,882 | 48.0% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 23 | 23 | $4,370 | $1,925 | 44.1% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 20 | 25 | $1,750 | $1,059 | 60.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 13 | 13 | $1,430 | $229.46 | 16.0% |
| 96127 | Brief emotional or behavioral assessment | Office | 2021 | 13 | 13 | $195.00 | $40.04 | 20.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 215 | 822 | $82,276 | $39,358 | 47.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 137 | 151 | $28,562 | $13,860 | 48.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 56 | 237 | $23,226 | $7,533 | 32.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 16 | 45 | $6,670 | $2,201 | 33.0% |
About Gladys Kimeli, NP
Gladys Kimeli, NP is a Family healthcare provider based in Saginaw, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/05/2018. The National Provider Identifier (NPI) number assigned to this provider is 1356823496.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Gladys Kimeli, NP has received a total of $13,154 in payments from pharmaceutical and medical device companies, with $5,491 received in 2024. These payments were reported across 665 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($10,832).
As a Medicare-enrolled provider, Kimeli has provided services to 809 Medicare beneficiaries, totaling 2,113 services with total Medicare billing of $117,780. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Other Specialties Psychiatric/Mental Health
- Location Saginaw, MI
- Active Since 09/05/2018
- Last Updated 03/02/2024
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1356823496
Products in Payments
- SPRAVATO (Drug) $3,131
- REXULTI (Drug) $1,464
- ARISTADA (Drug) $1,015
- VRAYLAR (Drug) $766.53
- QELBREE (Drug) $686.09
- ABILIFY MAINTENA (Drug) $683.59
- INGREZZA (Drug) $661.60
- TRINTELLIX (Drug) $584.34
- CAPLYTA (Drug) $538.44
- INVEGA SUSTENNA (Drug) $416.20
- Auvelity (Drug) $360.48
- JORNAY PM (Drug) $342.90
- LYBALVI (Drug) $309.72
- AUSTEDO (Drug) $293.35
- Qelbree (Drug) $207.73
- QUVIVIQ (Drug) $203.55
- Austedo XR (Drug) $151.80
- BRINTELLIX (Drug) $147.84
- Azstarys (Drug) $145.36
- PERSERIS (Drug) $137.26
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Saginaw
Helen Decorte, N.p, N.P
Family — Payments: $9,441
Family $9,441
Abraham Kimeli, Np, NP
Family — Payments: $9,354
Family $9,354
Mrs. Melissa Duron, Fnp, FNP
Family — Payments: $5,083
Family $5,083
Amber Fritzler
Family — Payments: $4,561
Family $4,561
Melissa Duchene, Fnp-Bc, FNP-BC
Family — Payments: $4,020
Family $4,020
Aubree Dalton, Fnp-Bc, FNP-BC
Family — Payments: $3,734
Family $3,734